LEADER 03891nam 2200565 450 001 9910484355303321 005 20231110212501.0 010 $a3-030-70270-7 035 $a(CKB)4100000011807059 035 $a(MiAaPQ)EBC6531759 035 $a(Au-PeEL)EBL6531759 035 $a(OCoLC)1247661486 035 $a(PPN)254722253 035 $a(EXLCZ)994100000011807059 100 $a20211016d2021 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAsthma $epathophysiology, herbal and modern therapeutic interventions /$fSheikh Rayees, Inshah Din 210 1$aCham, Switzerland :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (ix, 69 pages) $cillustrations 225 1 $aSpringerBriefs in Immunology 311 $a3-030-70269-3 327 $aIntro -- Introduction -- Contents -- Chapter 1: Asthma -- Chapter 2: Types of Asthma -- 2.1 Mild to Moderate Asthma -- 2.2 Severe Asthma -- 2.3 Pathophysiology Asthma -- 2.4 Interleukin-5 -- 2.5 Interleukin-13 -- 2.6 Interleukin-4 -- Chapter 3: Airway Inflammation and Airway Hyperresponsiveness -- Chapter 4: Effects of Inflammation -- 4.1 Effects on Airway Epithelia -- 4.2 Fibrosis -- 4.3 Mucus Hypersecretion -- 4.4 Airway Smooth Muscle -- Chapter 5: Inflammatory Cells Involved in Asthma -- 5.1 Eosinophils -- 5.2 Mast Cells -- 5.3 Macrophages -- 5.4 Dendritic Cells -- 5.5 CD4+T Cells -- 5.5.1 Activation and Differentiation -- 5.5.2 Th2 Cells and Asthma -- Chapter 6: Transcription Factors Involved in Th2 Cell Differentiation -- Chapter 7: Current Asthma Treatments -- 7.1 Inhaled Corticosteroids -- 7.2 Adverse Effects -- 7.3 Leukotriene Antagonists -- 7.4 Adverse Effects -- 7.5 Short-Acting Beta2 Agonists -- 7.6 Adverse Effects -- 7.7 Long-Acting Beta2 Agonists -- 7.8 Adverse Effects -- 7.9 Phosphodiesterase Inhibitors and Methylxanthines -- 7.10 Adverse Effects -- 7.11 Anticholinergics (Anti-muscarinic) -- 7.12 Adverse Effects -- Chapter 8: Cytokine-Based Therapies -- 8.1 Anti-IL-9 Therapy -- 8.2 Anti-IL-13 Therapy -- 8.3 Anti-IL-4 Therapy -- 8.4 Anti-IL-17 Therapy -- 8.5 Anti-IgE Therapy -- 8.6 Anti-IL-5 Therapy -- 8.7 Anti-TSLP -- Chapter 9: Transcription Factor Modulators -- 9.1 STAT6 -- 9.2 GATA3 -- 9.3 NF-?B and AP-1 -- Chapter 10: Preclinical Mouse Models of Asthma Used to Evaluate Drug Efficacy and Properties and Associated Drawbacks -- Chapter 11: Herbal Treatments of Asthma -- Chapter 12: Traditional Plants with Anti-asthmatic Potential -- Chapter 13: Asthma Chinese Herbal Remedies -- 13.1 Anti-asthma Herbal Medicine Intervention (ASHMI) -- 13.2 Modified Mai Men Dong Tang (mMMDT) -- 13.3 Ding Chuan Tang -- 13.4 STA-1. 327 $a13.5 Sophora flavescens Ait -- 13.6 Ma Huang -- 13.7 Minor Blue Dragon -- 13.8 Ginkgo biloba -- 13.9 Ginseng -- 13.10 Liquorice -- 13.11 Zizyphi fructus and Zizyphus jujuba -- 13.12 Cinnamon -- 13.13 Blipleuru -- 13.14 Sckisandra Ckintvisis -- 13.15 Ligusticum wallichii -- 13.16 Other Herbs -- Chapter 14: Future Potential of Herbal-Based Medicinal Treatment for Management of Asthma -- References. 410 0$aSpringerBriefs in Immunology 606 $aAsthma$xPathophysiology 606 $aAsma$2thub 606 $aFisiologia patolņgica$2thub 606 $aTerapčutica$2thub 606 $aFarmącia homeopątica$2thub 608 $aLlibres electrņnics$2thub 615 0$aAsthma$xPathophysiology. 615 7$aAsma 615 7$aFisiologia patolņgica 615 7$aTerapčutica 615 7$aFarmącia homeopątica 676 $a616.23807 700 $aRayees$b Sheikh$0846845 702 $aDin$b Inshah 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910484355303321 996 $aAsthma$91891942 997 $aUNINA